Kersten Dirk

CIK 00018236821 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001823682

Recent Transactions

50 trades

Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2025-05-30+35,000→ 35,000 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-09$29.18/sh−34,437→ 5,400,545 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-06$29.34/sh−101,675→ 5,434,982 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-05$29.05/sh−3,806→ 5,536,657 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-04$29.39/sh−135,039→ 5,540,463 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-03$29.05/sh−29,732→ 5,675,502 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-02$30.37/sh−1,228→ 5,705,234 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-12-02$29.66/sh−79,973→ 5,706,462 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-21$35.06/sh−121→ 73,104 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-18$35.16/sh−13,414→ 73,225 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-17$35.17/sh−13,013→ 86,639 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-16$35.35/sh−23,671→ 99,652 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-03$35.13/sh−5,441→ 123,323 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-02$35.38/sh−21,518→ 128,764 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-10-01$35.16/sh−8,423→ 150,282 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-30$36.02/sh−1,935→ 158,705 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-30$35.47/sh−29,007→ 160,640 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-27$35.00/sh−32→ 189,647 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-26$35.29/sh−1,260→ 189,679 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-25$35.06/sh−2,357→ 190,939 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-23$35.19/sh−36,221→ 197,906 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-23$36.33/sh−4,610→ 193,296 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-20$36.45/sh−78,940→ 234,598 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-20$37.01/sh−471→ 234,127 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-19$36.41/sh−50,972→ 313,538 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-19$35.74/sh−27,767→ 364,510 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-18$35.03/sh−1,554→ 392,277 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-17$35.13/sh−3,272→ 393,831 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-16$35.04/sh−1,320→ 397,103 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-05$35.03/sh−1,577→ 398,423 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-30$46.01/sh−6,204→ 400,000 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-30$45.49/sh−25,096→ 406,204 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-29$45.19/sh−45,640→ 442,068 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-29$45.81/sh−10,768→ 431,300 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-28$44.94/sh−61,467→ 487,708 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-28$44.41/sh−16,386→ 549,175 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-27$44.28/sh−65,403→ 565,561 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-26$45.23/sh−77,963→ 642,498 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-26$45.79/sh−11,534→ 630,964 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-23$46.37/sh−64,133→ 720,461 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-23$45.82/sh−20,955→ 784,594 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-22$46.97/sh−413→ 805,549 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-22$45.82/sh−94,908→ 805,962 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-21$46.52/sh−64,518→ 972,115 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-21$47.01/sh−71,245→ 900,870 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-20$45.68/sh−43,057→ 1,080,416 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-20$46.94/sh−35,457→ 1,044,959 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-20$47.30/sh−8,326→ 1,036,633 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$45.10/sh−30,448→ 1,219,057 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$46.01/sh−89,824→ 1,129,233 total

Companies

Dyne Therapeutics, Inc.
Director
$DYN

Recent Filings

Address

C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD

WALTHAM, MA, 02451

View on SEC.gov